Comment on

• HIV-1 infection in a man homozygous for CCR5 delta 32.

  O'Brien TR, Winkler C, Dean M, Nelson JA, Carrington M, Michael NL, White GC 2nd. O'Brien TR, et al. Lancet. 1997 Apr 26;349(9060):1219. doi: 10.1016/s0140-6736(97)24017-1. Lancet. 1997. PMID: 9130945 No abstract available.
• HIV-1 infection in an individual homozygous for CCR5 delta 32. Seroco Study Group.

  Theodorou I, Meyer L, Magierowska M, Katlama C, Rouzioux C. Theodorou I, et al. Lancet. 1997 Apr 26;349(9060):1219-20. Lancet. 1997. PMID: 9130946 No abstract available.
• Dual effect of CCR5 delta 32 gene deletion in HIV-1-infected patients. Copenhagen AIDS Study Group.

  Garred P, Eugen-Olsen J, Iversen AK, Benfield TL, Svejgaard A, Hofmann B. Garred P, et al. Lancet. 1997 Jun 28;349(9069):1884. doi: 10.1016/s0140-6736(05)63874-3. Lancet. 1997. PMID: 9217763 No abstract available.